Hospital Universitari de Santa Maria

Lleida 25198

1 studies enrolling now · 6 studies all time

What they study most

Agitation in Patients With Dementia of the Alzheimer's Type, Alzheimer's Disease, Alzheimer's Disease Dementia, Mild Cognitive Impairment Due to Alzheimer's Disease, Obesity, Overweight, Sleep Apnea, Obstructive

Studies at this site

• A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight — Recruiting now
• A Study to Learn About the Safety of Diranersen (BIIB080) Injections and Whether They Can Improve Symptoms of Participants With Mild Cognitive Impairment Due to Alzheimer's Disease (AD) or Mild AD Dementia Between 50 to 80 Years of Age — Running, not enrolling
• A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease — Stopped early
• A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205 — Stopped early
• Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type — Completed
• A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease — Completed